Collaborative trial platforms position themselves as the best method to achieve a drug for non-alcoholic fatty liver disease

by Vall d’Hebron

Collaborative platform trials subject patients to a unique selection process that makes them candidates for several treatment arms at the same time. The idea is to unify data analysis and standardize ...

Read more

Non-Alcoholic Steatohepatitis (NASH) Mechanisms and Models to Bring Attention to This Growing Epidemic

by CYTES BIOTECHNOLOGIES, SL.

Non-alcoholic steatohepatitis (NASH) is the advanced form of non-alcoholic fatty liver disease (NAFLD) characterized by an accumulation of fat in the liver cells that causes inflammation, ballooning o...

Read more

New key mechanism in the development of non-alcoholic fatty liver disease identified

by CIC bioGUNE

Alterations in neddylation have been shown to be involved in some liver diseases such as liver cancer, fibrosis and cirrhosis, and now in the development of non-alcoholic fatty liver disease. Pharmac...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream